Kesimpta is a medication used to treat relapsing forms of multiple sclerosis (MS) and clinically isolated syndrome (CIS). Kesimpta comes as a solution inside single-dose prefilled injection pens or ...
MS advocate and real estate investor Tamiko Ryan talks about the frustrations of getting proper treatments and shares strategies to help you get the support you need to manage MS and thrive. Multiple ...
Everyday Health on MSN
Understanding the Shift from Relapsing-Remitting MS to Secondary-Progressive MS
Be ready for the possible transition from RRMS to SPMS by understanding new symptoms, treatment options, and what to discuss ...
Many symptoms of MS are the same as those of other conditions. If you are concerned that you may have MS, make an appointment with your primary care provider. They will discuss your concerns and do a ...
Hosted on MSN
How to Manage Speech Problems Linked to MS
Multiple sclerosis (MS) is a chronic, often progressive disease that affects the central nervous system, including the brain, spinal cord, and optic nerves. While the most common symptoms include ...
Multiple sclerosis (MS) is a chronic disease of the central nervous system that causes disruptions in the flow of information within the brain and between the brain and body, eventually causing ...
The 41st ECTRIMS Congress kicks off in Barcelona, Spain, with a focus on advances in understanding and diagnosing MS.
A new version of the McDonald criteria — the official guidelines used to diagnose MS — aim to make MS diagnosis faster and ...
How Does Ocrevus or Ocrevus Zunovo Work in MS? MS happens when your immune system damages the protective covering around the nerves in your brain, called myelin. This affects how your brain ...
A novel program provided evidence that addressing long-known disparities in high-efficacy multiple sclerosis (MS) treatment for minority populations is a solvable problem. The program, presented by ...
News-Medical.Net on MSN
Researchers develop tool to predict how patients will respond to common multiple sclerosis drug
Brazilian researchers, in partnership with French institutions, have developed a tool that can predict how patients will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results